2 studies found for:    12177098 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Overcoming Endocrine Resistance in Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Lapatinib;   Drug: Aromatase Inhibitors;   Drug: Placebo Lapatinib
2 Recruiting Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment
Condition: Breast Cancer
Intervention:

Indicates status has not been verified in more than two years